NGM
Ngm Biopharmaceuticals Inc
Column Group L P bought $1.1M of Ngm Biopharmaceuticals Inc
Director and 10% owner
Bought$1,135,362
$17.65Price
64,313Shares
What NGM did for a copier
Prices for NGM after this filing aren't in yet.
Column Group L P's record
5 other buys with 3 months of prices since 2016: on average −28.4% against the S&P 500, and 0 of 5 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Thu, Aug 13. Filed Mon, Aug 17. Not investment advice.